InvestorFounders Fund is a venture capital firm based in the United States, founded in 2005. It invests in technology companies across various sectors and stages.

Alwyn Capital is a New York-based investment organization focused on early-stage biotechnology innovations aimed at reducing global dependence on animals. They target sectors such as food, fashion, and pharmaceuticals.
Online destinations
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Pages the organization runs itself.
Alwyn Capital is an investment organization founded to focus on biotechnology solutions. Based in New York, it aims to reduce global dependence on animals through innovative technologies. The organization invests in early-stage biotechnology innovations, particularly in food ingredients derived from plants, microbes, and cells, as well as non-animal materials and human organ-on-chip technology. Alwyn Capital addresses critical issues related to climate and human health, with a mission to support groundbreaking technologies that eliminate the need for animals in various industries.
Alwyn Capital specializes in early-stage biotechnology innovations, particularly those that focus on plant-based ingredients, microbial fermentation, and cultivated meat technologies. Their investments target solutions that address climate change and improve human health by replacing animal-derived products in food, fashion, and pharmaceuticals.
Alwyn Capital provides strategic support to its portfolio companies by leveraging industry expertise, fostering innovation, and connecting them with key partners in the biotechnology sector.
Alwyn Capital invests in early-stage biotechnology companies that focus on sustainable alternatives to animal products. They prioritize innovations in food, fashion, and pharmaceuticals that address climate change and human health.
Startups can pitch to Alwyn Capital through their website at alwyncapital.com. It is advisable to include a detailed deck that outlines the business model, technology, and market potential.
Alwyn Capital focuses specifically on biotechnology innovations that eliminate the need for animals. Their niche investment thesis targets sectors that are experiencing significant challenges, such as cellular agriculture and alternative proteins.
The firm primarily invests in the United States, focusing on early-stage companies that align with their mission to create sustainable solutions.
Alwyn Capital provides strategic support to its portfolio companies by leveraging industry expertise and connecting them with key partners in the biotechnology sector. This support is crucial for helping startups navigate the challenges of early-stage growth.
While specific check sizes are not disclosed, Alwyn Capital focuses on pre-seed, seed, and seed-plus stages, indicating that their investments are likely to be in the range typical for early-stage funding.
Superscout Pro
Is this page right?Reviewed · How the research works